Home Blog Page 3

Medicos designs the dropper system for SVR ampoules

By
The editorial staff
-
site-industries-cosmetiques A person holds a glass dropper above his hand, dispensing a white serum from a clear bottle labeled "SVR [A] Ampoule Flash", against a plain purple background.

Medicos has developed a dropper system for SVR's Ampoule range, combining a drawn glass pipette, TPE nipple and PP cap, mounted on a 30 ml molded glass bottle. The company details its integrated design and automated quality control features.

Medicos has designed a dropper system for SVR's Ampoule range, covering the Hydra, Lift, Anti-OX and Sebiaclear references. The device combines a drawn glass pipette, a PP pierced cap, a TPE nipple and a transport cap, assembled on a 30 ml molded glass bottle. Design and assembly are carried out in-house to ensure compatibility, functionality and reproducibility of components.

Pipette design and product management

The pipette has been dimensioned to limit the upwelling of liquid into the nipple, which contributes to the cleanliness of the packaging and the reduction of formula wastage. Medicos specifies that the pipette's dimensional parameters and shapes - round, curved or tapered tip and product passage diameter - enable it to be adapted to pharmaceutical and cosmetic uses.

Integrated chain and automated control

Medicos reports that design, manufacturing and assembly are fully integrated in-house, and that the company relies on Industry 4.0-style automated injection and assembly equipment, with camera-based control systems and AI-driven control. «This expertise is leading us to evolve our GMP standards, relying on Industry 4.0-style automated injection and assembly equipment, incorporating camera control systems and driven by AI. They contribute to consistent quality and industrial performance, and enable us to be competitive.», says Cédric Marmonier, founder and CEO of Medicos.

The range covers combinations of materials: bottles in drawn glass, molded glass or plastic; pipettes in glass or plastic; nipples in nitrile, butyl or TPE; caps in PP or RPP. Accessories (tamper-evident ring, pipette protector) and finishing options (mass tinting, aluminum cap, lacquering, metallization, marking, silk-screening) complete the range.

Product development is carried out within a certified quality framework and with an eco-design approach mentioned by the company, in line with regulatory developments such as PPWR.

Medicos now supplies this dropper system for SVR ampoules in 30 ml sizes, and points out that integrated control of all stages ensures reproducibility of components and control of functional parameters.

CCL Industries completes acquisition of Sleever and renames its activities

By
The editorial staff
-
site-industries-cosmetiques Close-up view of a machine applying labels to wine bottles fitted with corks on an automated production line. The bottles are moved by rollers and gears as part of the labeling process.

CCL Industries has announced the closing of its acquisition of Sleever International and the immediate renaming of its activities: label production becomes CCL Label, extruded films become Innovia Films, while equipment retains the Sleever brand. This operation combines sleeve capabilities, extruded films and application equipment for the consumer goods and healthcare markets.

The transaction takes over Sleever International Company SA, its subsidiaries and affiliates, and aims to integrate sleeve label manufacturing, extruded film production and the application equipment business into CCL Industries' operating perimeter. The equipment division will retain the Sleever name.

Renaming and operational responsibilities

The new activities are immediately renamed: the label and film businesses become CCL Label and Innovia Films respectively. Guenther Birkner, President of CCL Label's food & beverage sector and Innovia Films, «will now have overall responsibility for this acquisition».», according to the group. Éric Fresnel, Sleever's previous main shareholder, is to be retained. «in an advisory capacity».

Thomas Etien, Sleever International's Marketing, Communications and CSR Director, summarizes the activities and production capacities of Sleever International, which has recently been taken over by CCL Industries.

Industrial positioning

CCL Industries presents Sleever as a privately-owned manufacturer of shrink sleeve labels, extruded films and application equipment for customers in the consumer packaged goods and healthcare sectors. The parent company is already active in the conversion of extruded films and specialty materials, with processing including extrusion, adhesive development, coating and lamination.

The completion of the acquisition is in line with the continuity of CCL Industries' industrial capabilities, which also operate a large international production footprint. The transaction modifies the business architecture by renaming the operating entities and placing clear managerial responsibility under the leadership of Guenther Birkner.

Industrial wood for beauty packaging celebrates 25 years

By
The editorial staff
-
site-industries-cosmetiques Close-up view of an automated woodworking machine shaping circular wooden parts, with a "25 years beauty in wood" emblem in the upper right-hand corner.

Quadpack Wood celebrates 25 years of machining and producing wood packaging, with single-material mechanical technologies and processes powered by 100 % of renewable electricity.

Quadpack Wood is celebrating 25 years of activity dedicated to wood for the cosmetics sector, and boasts expertise covering closures, bottles and compact cases, integrated into the Quadpack group since 2013.

Woodacity: wood as a single-material mechanism

After two years of development with Shiseido, Quadpack Wood has patented Woodacity technology, which transforms wood into a single-material mechanical solution for closures. The technology gives wood precision mechanical performance and eliminates the need for intermediate materials in closures.

Upmarket and perfume/make-up applications

Production began on brand projects, from the first wooden cap for Burberry Touch for Women, to an all-wood perfume bottle for L'Eau d'Issey by Issey Miyake. Woodacity has evolved into Woodacity Hidden, a version that completely conceals the internal structure of the mechanism, used on Guerlain's Habit Rouge Spirit. A single-material cork and collar version was developed in collaboration with Puig for Adolfo Dominguez's ADN line.

Wood has also made its mark in make-up: for Guerlain's Terracotta collection, Quadpack Wood developed compact wooden cases combining precision machining and decorative finishes. The BeautyWood 2026 collection illustrates these turning, CNC milling and advanced decoration capabilities.

Production processes are based on 100 % renewable electricity and a biomass boiler that valorizes production offcuts for thermal systems and drying kilns. Wood is sourced from sustainably managed European forests, and the plant is FSC and Pefc certified.

Denisa Stircea, Senior Category Specialist, explains: «We are extremely proud to have pioneered the wood category in beauty packaging.»

The industrial roadmap mentions an increase in decoration capacity and a reduction in machining constraints, opening the way to new technical configurations for circular packaging.

The next product milestone identified in the source is the enhancement of the BeautyWood 2026 range as a showcase for tactile decoration techniques and complex geometries, to expand design possibilities while maintaining a single-material approach.

Arval launches Collageniques, a range based on NeoCollagen Complex

By
The editorial staff
-
site-industries-cosmetiques Five pink and white Arval Collageniques skincare products, including two jars, a pump bottle, a tube and a foam dispenser, are arranged on a round white display on a plain white background.

The brand enriches its Collageniques line with three new skincare products - cleansing foam, eye-lip contour and night mask - formulated around the NeoCollagen Complex to support collagen production and multi-level hydration.

Arval's Collageniques range is based on a core ingredient called NeoCollagen Complex, presented as a formulative technology designed to support natural collagen production and multi-level hydration.

The formulas combine NeoCollagen Complex and multi-molecular hyaluronic acid. After Plump Serum (30 ml) and Plump Cream (50 ml), Collageniques is expanding with Plump Cleansing Mousse, Plump Eyes & Lips and Plump Overnight Mask. The website lists Plump Serum at €68.00 and Plump Cream at €62.00.

Plump Overnight Mask is presented as a creamy texture designed to work overnight; Plump Cleansing Mousse combines NeoCollagen Complex and alfa-idrossiacidi with a gentle exfoliating action; Plump Eyes & Lips treatment targets smoothing and redensifying delicate areas.

Malvallin, The New Era of Skin Longevity for Structured and Expressive Skin

By
Croda Beauty
-
site-industries-cosmetiques A woman with radiant, structured skin smiles and looks to the side. The superimposed text reads: "in-cosmetics Award finalist CRODA Beauty". Abstract pink shapes are in the background.

Malvallin, The Smart, Multifunctional Active Dedicated to Proactive «Prejuvenation» Strategy, Redefines Structure, Volume and Natural expression.”

If you could reinforce your skin before the first signs even show, wouldn't that make your routine far more effective? Instead of correcting what's already visible, we can now work proactively on what shapes the face. With Malvallin™, you choose a smart, more intuitive active designed for true skin longevity, for all generations, with a Gen Y and Z focus.

In today's evolving beauty landscape, expectations are shifting. The pursuit of flawless, frozen perfection is gradually giving way to something more authentic: skin that feels alive, expressive and naturally balanced. This new mindset prioritizes presence over perfection, where vitality, structure and harmony define attractiveness far more than the absence of lines.

site-industries-cosmetiques Close-up of a person applying small dots of white cream to her cheek with her finger. The smooth, well-lit complexion highlights the benefits of structured skin, while the person's eye is partially visible.

Unlike traditional approaches that focus on correcting visible signs of ageing, Malvallin™ is the next-generation botanical active that embraces a proactive approach, one that works not by targeting isolated concerns, but by restoring coherence across the skin's entire architecture. Designed to act in depth, it supports the biological synchrony between the hypodermis, dermis and epidermis, where structure, volume and surface quality are intrinsically connected.

At the core of its performance lies the adiponectin signalling pathway, enabling simultaneous activity on adipocytes, fibroblasts and keratinocytes. This multi-layer mode of action allows Malvallin™ to engage adipocyte maturation, supporting subcutaneous volume, while stimulating extracellular matrix synthesis to reinforce dermal cohesion and firmness. At the epidermal level, it enhances barrier integrity through the stimulation of key lipids, including long-chain ceramides, alongside proteins involved in cohesion and defence.

This intelligent multifunctionality translates into visible, harmonious results. Facial contours appear naturally fuller, the skin feels firmer and more resilient, and the complexion becomes smoother, more radiant and more even. Redness is visibly reduced, while the overall appearance is refined, subtly sculpted, as if elevated from within.

Advanced evaluation methods further demonstrate this multi-dimensional efficacy. 3D volumetric imaging confirms visible support of cheek volume and improved facial contours, while targeted lipidomic analysis highlights a reinforced barrier composition. In parallel, eye-tracking technology reveals increased visual attention towards structurally enhanced areas of the face, objectively linking biological performance with perceived attractiveness.

site-industries-cosmetiques Side-by-side images of a woman's face show green and yellow dots on the heat map, indicating the focal points of eye tracking before and after 28 days of Malvallin treatment, with the increased intensity highlighting the expressive skin around the eyes and cheekbones.

What truly differentiates Malvallin™ is its ability to bridge deep biological action with visual and perceptible benefits. By working as a coherent system rather than a single-target solution, it creates multiple visible improvements through one intelligent mechanism, delivering elevated performance with refined simplicity.

This refined approach aligns perfectly with modern expectations. Consumers today seek simplicity without compromise: fewer steps, greater efficacy and results that feel intuitive rather than artificial. Malvallin™ delivers on this promise by combining depth of action with visible outcomes, offering a streamlined yet sophisticated solution for long-term skin health.

Ultimately, Malvallin™ represents more than an ingredient, it embodies a new vision of beauty. One where the goal is not to erase time, but to accompany it gracefully. By maintaining the skin's natural architecture and supporting its biological rhythm, it allows beauty to emerge with authenticity and confidence. 

In a world where sophistication lies in doing more with less, Malvallin™ sets a new standard, by enhancing what has always been there.

Malvallin™ from Croda Beauty is a patent-pending ingredient. It is preservative-free, 100% naturally derived according to ISO 16128, obtained from the fruit of cluster mallow, with botanical identity confirmed by marker Vicenin-II. It is COSMOS approved, RSPO and Halal certified, vegan compliant and IECIC listed.

It may be time to elevate your skin's performance, at every level.

More information about the product

Puig presents record results for 2025 and confirms its roadmap for 2026

By
The editorial staff
-
site-industries-cosmetiques A man wearing glasses, a gray suit and a black tie stands behind a podium inscribed with the word "PUIG" and speaks into a microphone against a plain light-colored background.

The Puig Group reported net sales of €5.042 million in 2025, up +7.8 1TP6Q like-for-like. The Annual General Meeting approved a dividend of €0.42159 per share and confirmed the 2026 guidance, with Capital Markets Day set for October 28 in Madrid.

Puig achieved net sales of €5.042 million in 2025, representing growth of +7.8 % like-for-like and +5.3 % on a reported basis. The Annual General Meeting approved the distribution of a total dividend of €0.42159 per share, and set the number of members of the Board of Directors at 13.

Renewals and appointments to the Board

Shareholders approved the re-election of Marc Puig as Executive Director and the appointment of Jose Manuel Albesa as Executive Director. Julie Van Ongevalle was appointed as a new independent director. The meeting also ratified the re-election of Nicolas Mirzayantz, Daniel Lalonde, Ángeles García-Poveda, Christine Ann Mei, Jordi Constans, Ioannis Petrides and Rafael Cerezo.

Strategic direction and timetable 2026

Puig CEO Jose Manuel Albesa reiterated the guidance for 2026 and announced a Capital Markets Day on October 28 in Madrid. He presented the new integrated organizational structure designed to simplify operations and support the growth of brands, markets and functions.

Marc Puig, Executive Chairman, recalled that recent strategic discussions with other groups had not led to a transaction, and confirmed that the family would remain a long-term shareholder. He emphasized the Group's historical trajectory and its objective of preparing for the next phase of growth while maintaining a solid financial base.

Speaking about Puig's future, Marc Puig said: «Puig is not for sale. We have always maintained that the family would remain a shareholder for the long term, which would have been the case even with the proposed combination. We have an exciting long-term ambition, a portfolio of highly desirable brands, a winning team, a very strong balance sheet and over 110 years of history to back up our vision.»

The meeting gave a favorable advisory opinion on the remuneration report and approved the remuneration policy for directors, as well as the authorization for future delivery of Class B shares for the variable components of executive remuneration.

The closing of the meeting focused on the continuation of the strategic plan after 2025 and the confirmation of a selective approach to external growth operations, with the Group targeting value-creating opportunities with a clear strategic fit.

Heppner makes Health & Beauty its top market

By
The editorial staff
-
site-industries-cosmetiques Two people in lab coats stand in front of shelves filled with medicines. One holds a bottle of pills while the other looks on. The setting appears to be that of a pharmacy or medical supply room.

The Health & Beauty segment represents 145 million euros in sales for Heppner. The group is strengthening its dedicated organization and has held Certipharm certification since 2012 for its land, air and sea-based activities.

Heppner has positioned the Health & Beauty segment as its leading market, supported by a dedicated organization and expertise built up over more than ten years. The group supports over 500 customers in the pharmaceutical, parapharmaceutical, medical device and cosmetics sectors.

Certipharm certification and quality network

Heppner has been Certipharm-certified since 2012 for its land, air and sea activities, attesting to compliance with Good Distribution Practices applicable to the transport of sensitive medicines and pharmaceutical products. The Group also has quality referents within its branches and implements ongoing training programs for its operational teams, from site managers to drivers.

Sales and customers

The Health & Beauty segment generates 145 million euros in sales for the Group, and includes over 500 customers in the pharmaceutical, parapharmaceutical, medical device and cosmetics industries. This activity is now the largest market in Heppner's business portfolio.

«In the health and beauty sectors, trust is built every day through quality of execution and the ability to secure often critical flows. Our role is to provide our customers with solutions that are reliable, compliant and agile enough to adapt to an ever-changing environment».», explains Laurent Rocchesani, Director of Health & Beauty at Heppner.

Driven by the growth of the health and beauty industries, the development of e-commerce and heightened expectations in terms of logistical resilience, the Health & Beauty segment represents an area of operational reinforcement for Heppner, with a focus on securing flows and continuity of supply.

Sales of sun creams and ointments up sharply on NewPharma

By
The editorial staff
-
site-industries-cosmetiques Screenshot of the Newpharma website displaying "sun" search results, with baby essentials, product filters on the left and lists of Avène and SVR suncare products with prices and discounts.
Screenshot

A heat wave in May led to a surge in purchases of suncare and repair products on NewPharma.fr, with notable sales increases in several categories.

NewPharma reports a clear shift in purchasing behavior due to the early heat of May, with sun protection and repair products leading the way in terms of volume.

Numerical increases by category

Sales of sun creams increased by a factor of 3 in the space of three days. Thermal sprays have risen by +170 % over three days since the peak of the heat. Sales of mosquito repellent products doubled as soon as the heat began.

Rehydration and repair products

Rehydration products containing electrolytes and trace elements doubled over one year, comparing May 2025 to May 2026. On Monday, the most frequent search on NewPharma.fr was for Cicabiafine, a repairing and healing ointment, reflecting strong demand for post-exposure care.

The early heat concentrated purchases usually spread over several weeks into a few days, with a particularly sharp peak on May 23, a trend confirmed over the whole month by NewPharma.

Solutions for heavy legs and circulation have also doubled, reflecting the impact of higher temperatures on vascular discomfort.

Seppic unveils «The tail-ored pet care collection»

By
The editorial staff
-
site-industries-cosmetiques A variety of skincare and cosmetic product textures are arranged on a luminous surface, including creamy, foamy and gelatinous substances of different shapes and sizes.

Seppic presents a kit of six formulations based on its Sepifriend ingredients for a 3-step care and hygiene routine, tested in vitro on reconstituted canine epidermis.

Seppic publishes «The tail-ored pet care collection», a kit of six formulations designed for the care and hygiene of pets. The collection is based on Sepifriend ingredients and a three-step approach for dogs, cats and horses.

A kit of six formulations and a 3-step routine

The collection includes six formulations based on a «3-step care and hygiene routine»:

  • step 1: cleanse sensitive areas - soothing eye contour cleanser, gentle ear lotion.
  • stage 2: coat and skin care - ultra-gentle moisturizing and soothing shampoo, cleansing and purifying leave-in foam.
  • step 3: care for specific areas - spray shine and coat care, balm centella asiatica for the nose and pads.

Sepifriend ingredients, safety and performance forms

The kit features functional ingredients: sulfate-free foaming agents, solubilizers, rheology modifiers, emulsifiers and emollients. Sepifriend active ingredients are presented as providing benefits identified in the source text: long-lasting hydration, soothing effects, accelerated skin repair and dermo-purifying properties.

Given the specific physiological characteristics of animals , «Animal skin is 3 to 5 times thinner than human skin and maintains a more neutral pH.», the collection combines high naturalness with regulatory compliance.

The ingredients have been tested in vitro on «reconstituted canine epidermis», «demonstrating no impact on tissue viability and suggesting their suitability for both rinse-off and rinse-in applications.»

Hervé Hoppenot appointed Chairman of the Board of Pierre Fabre

By
The editorial staff
-
site-industries-cosmetiques A dark-haired man wearing a blue suit jacket and white shirt stands in front of a plain dark-blue background, smiling and arms loosely crossed.

Pierre Fabre Participations has appointed Hervé Hoppenot as Chairman of the Board of Directors of Pierre Fabre SA, an appointment approved by the Board at its meeting on May 21. This decision is accompanied by the appointment of Roch Doliveux as Vice-Chairman.

Hervé Hoppenot has been appointed Chairman of the Board of Directors of Pierre Fabre SA, a decision endorsed by the Board of Directors on May 21. A director since January 15, 2024, he succeeds Roch Doliveux, now Vice-Chairman.

Executive career and mandates held

Hervé Hoppenot, 65, a dual French-American citizen, led biotech Incyte as president and CEO from 2014 to 2025. He was also President of Novartis' global oncology franchise. In parallel with his new role at Pierre Fabre, he chairs the board of Maze Therapeutics and sits on the boards of Bicycle Therapeutics and N-Power Medicine.

Group succession and governance

Pierre Fabre Participations, the Group's controlling holding company, made the appointment. Pierre Yves Revol, Chairman of Pierre Fabre Participations, comments on the succession between Roch Doliveux and Hervé Hoppenot, recalling the 2017-2026 period covered by the previous chairmanship.

Hervé Hoppenot declared: «I'm very happy to bring my expertise to an independent group, strongly rooted in its territory and a major player in the health and beauty sector. It's an honor for me to have the opportunity to help Group CEO Eric Ducournau to develop the business as he has been doing since 2019, and to contribute to the development of a highly virtuous group, owned by a Foundation recognized as being in the public interest, the recipient of profits distributed by the company to develop action programs for the benefit of the most disadvantaged in terms of healthcare in the least favored countries.».

Sophie Le Tanneur joins the Board of Directors of Pierre Fabre SA as a Director; she also sits on the Boards of Groupe Bollinger and CIS Catering.

The next institutional milestone mentioned is the continuity of the executive mandate, with Eric Ducournau in post as CEO from 2019.

1234...305Page 3 of 305

Our last issue

Listen to us!

Consult our media kit

Newsletter